A Survey to Evaluate the Rate of Abnormal Glucose Tolerance Among Hong Kong Chinese Subjects With Coronary Heart Disease
A Cross-sectional Observational Survey to Evaluate the Rate of Diabetes and Glucose Intolerance (Both Diagnosed and Undiagnosed) Among Hong Kong Chinese Subjects With Coronary Heart Disease
1 other identifier
observational
N/A
1 country
1
Brief Summary
Hypothesis: there is a high prevalence rate of diabetes, including asymptomatic undiagnosed glucose intolerance, among subjects with coronary heart disease in Hong Kong. A cross-sectional survey is planned to study the rate of undiagnosed diabetes and glucose intolerance among the Chinese patients with coronary heart disease in Hong Kong. The survey results will be important for us to plan the logistics to investigate and manage the potential glucose abnormality of our heart disease patient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
November 5, 2008
CompletedFirst Posted
Study publicly available on registry
November 6, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedAugust 24, 2015
August 1, 2015
10.2 years
November 5, 2008
August 21, 2015
Conditions
Eligibility Criteria
Hong Kong Chinese with history of coronary heart disease being diagnosed in 2008 in HA hospitals
You may qualify if:
- Patients aged 18 years
- Subjects admitted to Hospital Authority hospital as in-patients (AHNH) with the diagnosis of coronary heart disease (ICD code 410-414) during the period 1 April 2007 to 31 March 2008.
- Subjects admitted to AHNH for the procedure Percutaneous Coronary Intervention (PCI) to manage coronary heart disease.
You may not qualify if:
- Known Type 1 diabetes defined as history of ketosis \[acute symptoms with heavy ketonuria (\>3+) or ketoacidosis\] or heavy ketonuria (3+) or continuous requirement of insulin treatment within one year of diagnosis and thereafter.
- Patients with terminal malignancy or other life-threatening diseases with less than 6-month expected survival
- Patients with a mental condition rendering the subject unable to understand the nature, scope, and possible consequences of the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hong Kong Institute of Diabetes and Obesity
Hong Kong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gary Ko, MD
Asia Diabetes Foundation
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chair Professor of Medicine and Therapeutics
Study Record Dates
First Submitted
November 5, 2008
First Posted
November 6, 2008
Study Start
October 1, 2008
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
August 24, 2015
Record last verified: 2015-08